Emcure Pharmaceuticals Ltd.
Industry:
Pharmaceuticals & Drugs
Issue Details
Open Date
03 Jul 2024Close Date
05 Jul 2024Size (in Crs.)
1381.32
Size (Shares)
-Listing On
BSE, NSE
Issue Terms
Price Range
-48Lot Size
14
Type
Book building
Face Value
10
Market Lot
1
Objective of the Issue
1. Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by our Company; and2. General corporate purposes.
Description
We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. We were ranked as (i) the 12th largest pharmaceutical company in India and (ii) the largest pharmaceutical company in India in the gynecology, blood related and HIVantivirals therapeutic areas, based on sales in India in the Financial Year 2021, according to CRISIL. We are an R&D drivencompany with a differentiat... Show More
Address
Plot No. P-1 & P-2 , I T - B T Park, Phase- I I , M I D C, Hinjawadi
Pune
411057
Promoter Holding
Promoters:
Namita Vikas Thapar, Samit Satish Mehta, Satish Ramanlal Mehta, Sunil Rajanikant Mehta
Total Share Capital
150730468
Offered to Public
19375070
% Promoter's Holding (Pre-Issue)
83.21
% Promoter's Holding (Post-Issue)
78.11
Shares on offer
Total Share Offer
150730468
Of above offred to public
19375070
Post Issue shares
NA
Post Issue Promoters
78.11
Lead Managers to the Issue:
Axis Capital Ltd., Jefferies India Pvt Ltd., JP Morgan India Pvt Ltd, Kotak Mahindra Capital Co Ltd
Registrar Details
Registrar Name:
MUFG Intime India Pvt Ltd.
Address
C 101, 247 Park , LBS Marg , Vikhroli (West) , Mumbai
400083
Phone No.
+91 810 811 8484
Website
https://in.mpms.mufg.com/
Fax
91-022-49186060